"From Innovation to Market: Lessons and Challenges from In Silico CM&S Disruption in Biotech and Pharma’s Predictive Toxicology"
Tuesday February 18th 2025, 5 PM CET
Topic:
"From Innovation to Market: Lessons and Challenges from In Silico CM&S Disruption in Biotech and Pharma’s Predictive Toxicology“.
This session will explore how in silico predictive toxicology, driven by (Q)SAR methodologies, has revolutionized regulatory and industry approaches, offering invaluable insights into scaling CM&S innovations to meet industry demands.
Key Takeaways:
Speaker:
Dr. Matthieu CHAREYRE, from Tox by Design, a visionary entrepreneur and regulatory expert, will share his extensive experience in in silico toxicology, biotech GMP scale-up, and strategic management.
